Navigation Links
Agendia Appoints Seasoned Diagnostics Executive Albert A. Luderer to Supervisory Board
Date:3/5/2009

HUNTINGTON BEACH, California and AMSTERDAM, March 5 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, today announced the appointment of Dr. Albert A. (Al) Luderer to its Supervisory Board.

Dr. Luderer has more than 30 years of experience in in vitro medical diagnostics, laboratory medicine and therapeutic development. Currently, he is the Chief Executive Officer and President of BioTrove, a privately held company using innovative platform technologies to dramatically increase throughput for pharmaceutical screening and genomics research, accelerating drug-discovery decisions and pipeline development. Dr. Luderer is also the Director of Light Micronics, Inc. and a Scientific Advisory Board member at Washington University's Department of Biomedical Engineering, St. Louis, MO.

"We are very pleased to welcome Al to our Supervisory Board," commented Bernhard Sixt, Ph.D., President and Chief Executive Officer of Agendia. "As we continue to expand our U.S. activities, Al's extensive experience and track record of success in the diagnostics industry will prove extremely valuable to Agendia's growth." Previously, Dr. Luderer served as Director, President and Chief Executive Officer of Light Sciences Corporation where he spearheaded the company's combined business, technical and commercial activities. Prior to joining Light Sciences Corporation, Dr. Luderer was President and Chief Operating Officer at bioMerieux, Inc., a world leader in in vitro diagnostics. From 1987 - 1993, Dr. Luderer was at Boehringer Mannheim Corporation (now Roche) where he was named Vice President of Technology Development and Support. He started his work in the sector at Corning Inc. as a key figure negotiating the joint venture diagnostic company Ciba Corning (now Siemens Healthcare Diagnostics).

Dr. Luderer holds a Bachelor of Arts from Drew University and an M.S. and Ph.D. from
'/>"/>

SOURCE Agendia B.V.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Agendia Publishes Direct Evidence That MammaPrint Predicts Benefit of Chemotherapy in Breast Cancer
2. Agendia Appoints VP of Business Development
3. Agendias Breast Cancer Test MammaPrint(R) Standard of Care at Netherlands Cancer Institute - AVL
4. Agendia Appoints New Chief Financial Officer
5. Agendia and Ferrer Announce Exclusive Agreement for Sales of Cancer Diagnostic Services in Four Major European Markets
6. Agendias MammaPrint(R) Receives Prestigious Award From Dutch Innovation Platform
7. Agendia and Agilent Announce Plans to Jointly Develop New Diagnostic Tests, Extend Supply Agreement
8. Agendia BV Appoints Clinical and Scientific Advisory Board
9. Agendia BV Announces That its Chief Research Officer Laura van t Veer has Received a 2007 Breast Cancer Research Foundation Award
10. Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to a Herceptin(R) Sensitivity Test
11. Agendia Joins the Personalized Medicine Coalition (PMC)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... WIEN , July 3, 2015 /PRNewswire/ ... opplæringsprogrammet "Lab for Open Innovation in Science", ... . Søknadene sendes på nett, på  ... 22. september 2015.  De to ... insentiver til å undersøke nye forskningsspørsmål og ...
(Date:7/2/2015)... , July 2, 2015  Spherix Incorporated (Nasdaq: ... the fostering and monetization of intellectual property, today announced ... Spherix Incorporated v. Verizon Services Corp. et al. ... Court for the Eastern District of Virginia ... July 1, 2015 interpreting certain key claims in favor ...
(Date:7/1/2015)... and PARIS , July ... and Genective, key developer of biotech crops, today ... of new generations of insect control traits. ... to counter the realities of advancing insect resistance. ... AgBiome,s unique insect control technology with Genective,s capability ...
(Date:7/1/2015)...  Axovant Sciences Ltd. (NYSE:  AXON), a leading ... dementia, today announced that the company will host ... p.m. EDT following its presentation of RVT-101 clinical ... (AAIC). The event will include ... Lawrence Friedhoff , Chief Development Officer, will present ...
Breaking Biology Technology:Lansering av verdens første Open Innovation-program for utdanning av forskere 2Lansering av verdens første Open Innovation-program for utdanning av forskere 3Spherix Issues A Litigation Update 2Spherix Issues A Litigation Update 3AgBiome and Genective collaborate to create novel insect-resistant crops 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3
... a significant milestone for the growing open source clincial trials ... towards the needs of regulated industry sponsored clinical trials. ... ... 2008 -- Akaza Research announces the availability of OpenClinica 2.5, ...
... Gen-Probe Incorporated,(Nasdaq: GPRO ) announced today that the ... on Wednesday, September 24, 2008 at noon,Eastern Time. The ... be,accessed through a link on the investors section of ... available for 30 days,following the event., About Gen-Probe, ...
... 19 /Xinhua-PRNewswire-FirstCall/ --,China-Biotics, Inc. (OTC Bulletin Board: ... specializing in the manufacture,research, development, marketing and ... its 2008 Annual General Meeting of Shareholders,(the ... nominees to the,Board of Directors., At ...
Cached Biology Technology:Akaza Research Releases New Version of OpenClinica Electronic Data Capture (EDC) Software; Targets Industry Clinical Trials 2Akaza Research Releases New Version of OpenClinica Electronic Data Capture (EDC) Software; Targets Industry Clinical Trials 3Gen-Probe to Webcast Presentation at the UBS Global Life Sciences Conference 2China-Biotics, Inc. Announces Results of 2008 Annual General Meeting of Shareholders 2
(Date:6/24/2015)... , June 24, 2015 The biologics ... The major drivers for the market include growth of ... of new drug launches. Over the years, the number ... Between 2001 and 2010, the FDA approved 225 drug ... to WIPO, Europe accounted for ...
(Date:6/23/2015)... 2015   MedNet Solutions , an innovative ... spectrum of clinical research, is pleased to announce ... the company,s intuitive, flexible and affordable cloud-based eClinical ... Stevie® Award by the American Business Awards ... category.  The American Business Awards are considered the ...
(Date:6/18/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... mobile commerce market announces that its Wocket® smart wallet will ... the Mark", scheduled to air on WABC Radio (am770) in ... . The broadcast air- time for the ... EST. NXT-ID, Inc.,s CEO Gino Pereira will be ...
Breaking Biology News(10 mins):Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3
... experts from across federal science agencies will gather in ... research priorities, exploring research performance management, and assessing the ... is to develop a collaborative framework to ensure future ... a coordinated manner. "We are bringing together ...
... how important it is for pregnant women to eat good, ... to have children who are less likely to develop type ... Sahlgrenska Academy at the University of Gothenburg, Sweden. ... which is conducting a population study called ABIS (All Babies ...
... research team has been awarded $6.27 million to develop ... more energy efficient at home. The funding, which covers ... of Energy,s Advanced Research Projects Agency-Energy (ARPA-E), About $1.28 ... Stanford and the California Energy Commission. The Stanford ...
Cached Biology News:Vegetables can protect unborn child against diabetes 2Stanford researchers awarded $6.27 million to study energy efficiency and human behavior 2
... antibody detects an ~185 kDa protein, corresponding ... phosphorylated at tyrosine 1248 on SDS-PAGE immunoblots. ... adsorbed against the non-phosphorylated peptide to remove ... of the protein. In cell lines ...
Mouse monoclonal [4A2.2] to SLC6A4 ( Abpromise for all tested applications). entrezGeneID: 6532 SwissProtID: P31645...
...
... provides all the accessories necessary for casting ... polymorphism analysis (SSCP) with the DCode universal ... cooling finger adaptor for use with an ... 20 cm plates, 2 sets of 0.75 ...
Biology Products: